Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Oper Orthop Traumatol ; 36(2): 132-144, 2024 Apr.
Article in English | MEDLINE | ID: mdl-37828133

ABSTRACT

OBJECTIVE: Osteochondral lesions of the talus (OLT) with a fragment on the talar dome that fail conservative treatment and need surgical treatment can benefit from in situ fixation of the OLT. Advantages of fixation include the preservation of native cartilage, a high quality subchondral bone repair, and the restoration of the joint congruency by immediate fragment stabilization. To improve the chance of successful stabilization, adequate lesion exposure is critical, especially in difficult to reach lesions located on the posteromedial talar dome. In this study we describe the open Lift, Drill, Fill, Fix (LDFF) technique for medial osteochondral lesions of the talus with an osteochondral fragment. As such, the lesion can be seen as an intra-articular non-union that requires debridement, bone-grafting, stabilization, and compression. The LDFF procedure combines these needs with access through a medial distal tibial osteotomy. INDICATIONS: Symptomatic osteochondral lesion of the talus with a fragment (≥ 10 mm diameter and ≥ 3 mm thick as per computed tomography [CT] scan) situated on the medial talar dome which failed 3-6 months conservative treatment. CONTRAINDICATIONS: Systemic disease, including active bacterial arthritis, hemophilic or other diffuse arthropathies, rheumatoid arthritis of the ankle joint, and malignancies. Neuropathic disease. End-stage ankle osteoarthritis or Kellgren and Lawrence score 3 or 4 [3]. Ipsilateral medial malleolus fracture less than 6 months prior. Relative contra-indication: posttraumatic stiffness with range of motion (ROM) < 5°. Children with open physis: do not perform an osteotomy as stabilization of the osteotomy may lead to early closure of the physis, potentially resulting in symptomatic varus angulation of the distal tibia. In these cases only arthrotomy can be considered. SURGICAL TECHNIQUE: The OLT is approached through a medial distal tibial osteotomy, for which the screws are predrilled and the osteotomy is made with an oscillating saw and finished with a chisel in order to avoid thermal damage. Hereafter, the joint is inspected and the osteochondral fragment is identified. The cartilage is partially incised at the borders and the fragment is then lifted as a hood of a motor vehicle (lift). The subchondral bone is debrided and thereafter drilled to allow thorough bone marrow stimulation (drill) and filled with autologous cancellous bone graft from either the iliac crest or the distal tibia (fill). The fragment is then fixated (fix) in anatomical position, preferably with two screws to allow additional rotational stability. Finally, the osteotomy is reduced and fixated with two screws. POSTOPERATIVE MANAGEMENT: Casting includes 5 weeks of short leg cast non-weightbearing and 5 weeks of short leg cast with weightbearing as tolerated. At 10-week follow-up, a CT scan is made to confirm fragment and osteotomy healing, and patients start personalized rehabilitation under the guidance of a physical therapist.


Subject(s)
Intra-Articular Fractures , Talus , Child , Humans , Talus/diagnostic imaging , Talus/surgery , Treatment Outcome , Tibia/surgery , Autografts , Osteotomy/methods , Ankle Joint/diagnostic imaging , Ankle Joint/surgery
2.
Acta Orthop Belg ; 88(3): 581-587, 2022 Sep.
Article in English | MEDLINE | ID: mdl-36791713

ABSTRACT

Osteochondritis dissecans as a pathology is pre-dominantly described in the knee, elbow and ankle. Osteochondritis dissecans of the humeral head is a more uncommon reported injury. We present a case of a bilateral osteochondritis dissecans of the humeral head in a 16-year-old soccer player and an algorithm for treatment of OCD of the humeral head. To our knowledge this has never been described so specifically in literature before.


Subject(s)
Elbow Joint , Osteochondritis Dissecans , Humans , Adolescent , Shoulder , Osteochondritis Dissecans/diagnostic imaging , Osteochondritis Dissecans/surgery , Humeral Head , Knee Joint/pathology
3.
Int Orthop ; 43(12): 2739-2745, 2019 12.
Article in English | MEDLINE | ID: mdl-31115598

ABSTRACT

PURPOSE: The purpose of this study was to assess whether unicompartmental knee arthroplasty (UKA) results in better patient-reported and clinical outcome than total knee arthroplasty (TKA). The study hypothesis was UKA yields better patient-reported and clinical outcomes than TKA. METHODS: Our prospective cohort study compared patients who underwent medial UKA or TKA from February 2014 through June 2015. Forgotten Joint Score (FJS), the short form of the Knee Injury and Osteoarthritis Outcome Score (KOOS PS), EuroQOL Five Dimensions Questionnaire (EQ-5D), and the Knee Society Score (KSS) were completed at two weeks, six weeks, three months, six months, and one year post-operatively. The KOOS PS, EQ-5D, and the KSS were also documented pre-operatively. RESULTS: Fifty-seven patients (57 knees) were allocated to the UKA group and 62 patients (62 knees) to the TKA group. At baseline, no statistically significant differences were observed between groups regarding patient demographics and pre-operative scores. Except for FJS at 2 weeks (p = 0.326), all postoperative scores revealed significant differences as early as two weeks and up to 12 months (p < 0.05). CONCLUSIONS: Our findings suggest UKA patients are less aware of their joint replacements than TKA patients for medial osteoarthritis of the knee. UKA conserves more soft tissue and bone than TKA, which may be the reason for the differences observed.


Subject(s)
Arthroplasty, Replacement, Knee , Knee Joint/surgery , Aged , Arthroplasty, Replacement, Knee/methods , Female , Humans , Male , Middle Aged , Postoperative Period , Prospective Studies , Treatment Outcome
4.
Epilepsia ; 58(9): 1615-1625, 2017 09.
Article in English | MEDLINE | ID: mdl-28722103

ABSTRACT

OBJECTIVE: Urokinase-type plasminogen activator (uPA) and kallikrein-related peptidase 8 (KLK8) are serine proteases that contribute to extracellular matrix (ECM) remodeling after brain injury. They can be labelled with the novel radiotracer [111 In]MICA-401. As the first step in exploring the applicability of [111 In]MICA-401 in tracing the mechanisms of postinjury ECM reorganization in vivo, we performed in vitro and ex vivo studies, assessing [111 In]MICA-401 distribution in the brain in two animal models: kainic acid-induced status epilepticus (KASE) and controlled cortical impact (CCI)-induced traumatic brain injury (TBI). METHODS: In the KASE model, in vitro autoradiography with [111 In]MICA-401 was performed at 7 days and 12 weeks post-SE. To assess seizure burden, rats were monitored using video-electroencephalography (EEG) for 1 month before the 12-week time point. In the CCI model, in vitro autoradiography was performed at 4 days and ex vivo autoradiography at 7 days post-TBI. RESULTS: At 7 days post-SE, in vitro autoradiography revealed significantly decreased [111 In]MICA-401 binding in hippocampal CA3 subfield and extrahippocampal temporal lobe (ETL). In the chronic phase, when animals had developed spontaneous seizures, specific binding was decreased in CA3 and CA1/CA2 subfields of hippocampus, dentate gyrus, ETL, and parietal cortex. Of interest, KASE rats with the highest frequency of seizures had the lowest hippocampal [111 In]MICA-401 binding (r = -0.76, p ≤ 0.05). Similarly, at 4 days post-TBI, in vitro [111 In]MICA-401 binding was significantly decreased in medial and lateral perilesional cortex and ipsilateral dentate gyrus. Ex vivo autoradiography at 7 days post-TBI, however, revealed increased tracer uptake in perilesional cortex and hippocampus, which was likely related to tracer leakage due to blood-brain barrier (BBB) disruption. SIGNIFICANCE: Strong association of reduced [111 In]MICA-401 binding with seizure burden in the KASE model suggests that analysis of reduced levels of active uPA/KLK8 represents a novel biomarker candidate to be explored as a biomarker for epilepsy severity. However, limited BBB permeability of [111 In]MICA-401 currently limits its application in vivo.


Subject(s)
Epilepsy, Temporal Lobe/metabolism , Kallikreins/metabolism , Seizures/metabolism , Urokinase-Type Plasminogen Activator/metabolism , Animals , Disease Models, Animal , Electroencephalography , Male , Rats , Rats, Sprague-Dawley , Status Epilepticus/metabolism , Video Recording
SELECTION OF CITATIONS
SEARCH DETAIL
...